FDA Accepts Amgen's New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Amgen Inc (NASDAQ: AMGN) | Delayed: 447.28 +8.94 (2.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $438.34 | 52 Week High | $176.85 | |||
| Open | $441.55 | 52 Week Low | $133.64 | |||
| Day High | $450.98 | P/E | 67.36 | |||
| Day Low | $437.19 | EPS | $6.64 | |||
| Volume | 3,104,562 | |||||
